A human antibody against Zika virus crosslinks the E protein to prevent infection (scientific article (publication date: 16 March 2017))

Notes from the Field : Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses — Brazil, 2015

Q24261163

Phylogeny of the genus Flavivirus

Q24471099

Structural proteomics of dengue virus

Q24658386

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Q24736810

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

Q24737245

Structural basis of potent Zika–dengue virus antibody cross-neutralization

Q24740325

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

Q25161212

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus

Q26247258

Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection

Q26252507

Structures of immature flavivirus particles

Q27477478

Structure of the dengue virus envelope protein after membrane fusion

Q27643009

Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation

Q27643140

Structure of the immature dengue virus at low pH primes proteolytic maturation

Q27650165

Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354

Q27665151

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

Q27681306

Recognition determinants of broadly neutralizing human antibodies against dengue viruses

Q27697333

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

Q27730234

Coot: model-building tools for molecular graphics

Q27860505

UCSF Chimera--a visualization system for exploratory research and analysis

Q27860666

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega

Q27860809

Neutralization mechanism of a highly potent antibody against Zika virus

Q27924235

Single particle cryo-electron microscopy and 3-D reconstruction of viruses

Q28660278

RELION: implementation of a Bayesian approach to cryo-EM structure determination

Q29547673

Prevention of overfitting in cryo-EM structure determination

Q29614287

Appion: an integrated, database-driven pipeline to facilitate EM image processing

Q29614288

Deciphering key features in protein structures with the new ENDscript server

Q29617219

Conformational changes of the flavivirus E glycoprotein

Q29618170

H7N9 influenza virus neutralizing antibodies that possess few somatic mutations

Q30385356

Tilt-pair analysis of images from a range of different specimens in single-particle electron cryomicroscopy

Q34027984

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

Q35138111

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

Q35654743

An algorithm for estimation and correction of anisotropic magnification distortion of cryo-EM images without need of pre-calibration

Q36043129

Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding

Q36063949

DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers

Q36352752

2.9 Å Resolution Cryo-EM 3D Reconstruction of Close-Packed Virus Particles

Q36540500

Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus

Q38782718

Leginon: an automated system for acquisition of images from vitreous ice specimens.

Q39554639

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

Q40052932

Structural Basis of Zika Virus-Specific Antibody Protection

Q40056291

Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers

Q40185021

P275

Creative Commons Attribution 4.0 International

copyrighted

language of work or name

English

Q1860

P921

main subject

antibody

Zika virus

Zika virus infection

Zika virus proteome

on focus list of Wikimedia project

WikiProject Zika Corpus

Q54439832

P304

page(s)

14722

P577

publication date

2017-03-16

P1433

published in

Nature Communications

Q573880

P1476

title

A human antibody against Zika virus crosslinks the E protein to prevent infection

P478

volume

Reverse relations

cites work (P2860)

Q47193184	A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.
Q84957921	A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein
Q93065042	A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection
Q38156667	Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives
Q55084443	Advances in the research and development of therapeutic antibodies against the Zika virus.
Q51336416	Adverse outcomes of pregnancy-associated Zika virus infection.
Q59349915	Antibody responses to Zika virus proteins in pregnant and non-pregnant macaques
Q83225458	Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
Q61053646	CD4+ T cells promote humoral immunity and viral control during Zika virus infection
Q98205356	Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor
Q64979406	Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model.
Q47549528	Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
Q92507592	Cryo-EM Studies of Virus-Antibody Immune Complexes
Q91711499	Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade
Q61795509	Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
Q91876510	Development and Characterization of a Potent Tumor Necrosis Factor-Alpha-Blocking Agent
Q47558158	Development of Antibody Therapeutics against Flaviviruses
Q64247461	Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure
Q92188514	Development of Small-Molecule Inhibitors Against Zika Virus Infection
Q38156855	Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus
Q47558315	Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity
Q47551925	Immune Response to Dengue and Zika
Q97646317	Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection
Q89965788	Maternal-Fetal Interplay in Zika Virus Infection and Adverse Perinatal Outcomes
Q52431569	Microbiology catches the cryo-EM bug.
Q54217627	Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Q38157121	Monoclonal antibodies against Zika virus: Therapeutics and their implications for vaccine design
Q49791115	N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut Invasion by Flaviviruses
Q47263584	Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge
Q92343941	Peptide-Based Subunit Vaccine Design of T- and B-Cells Multi-Epitopes against Zika Virus Using Immunoinformatics Approaches
Q54231305	Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins.
Q38157816	Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice
Q40043685	Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design
Q54221789	Probing Molecular Insights into Zika Virus⁻Host Interactions.
Q43039888	RNA-dependent RNA polymerase: Addressing Zika outbreak by a phylogeny-based drug target study
Q54215484	Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
Q38158407	Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure
Q55567656	Refinement and Analysis of the Mature Zika Virus Cryo-EM Structure at 3.1 Å Resolution.
Q33888270	Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants
Q61053963	Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
Q90113577	Structures of enveloped virions determined by cryogenic electron microscopy and tomography
Q47558217	The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.
Q92619848	ZIKV Envelope Domain-Specific Antibodies: Production, Purification and Characterization
Q47558310	Zika Virus Structure, Maturation, and Receptors

P819	ADS bibcode	2017NatCo...814722H
P6179	Dimensions Publication ID	1084128945
P356	DOI	10.1038/NCOMMS14722
P932	PMC publication ID	5356071
P698	PubMed publication ID	28300075